Travere Therapeutics, Inc. (TVTX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.55 |
| Open | 7.40 |
| Bid | 6.75 x 900 |
| Ask | 6.78 x 800 |
| Day's range | 6.74 - 7.69 |
| 52-week range | 5.12 - 19.54 |
| Volume | |
| Avg. volume | 1,267,952 |
| Market cap | 513.871M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Travere Therapeutics...
- GuruFocus.com
Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
Discover how Travere Therapeutics Inc (TVTX) achieved a robust revenue increase and navigated regulatory landscapes in the first quarter of 2024.
- Simply Wall St.
Travere Therapeutics (NASDAQ:TVTX) shareholders have endured a 74% loss from investing in the stock three years ago
As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses...
© 2024 Yahoo. All rights reserved.